NADI-351 is an orally active and potent Notch1 inhibitor that selectively disrupts Notch1 transcription complexes and reduces Notch1 recruitment to target genes. NADI-351 can be utilized in cancer research[1].
Molecular Weight:
465.52
Purity:
99.83
CAS Number:
[2503017-11-4]
Formula:
C19H20FN5O4S2
Target:
Notch
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted